Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
76.43
+0.93 (1.23%)
Aug 12, 2026, 10:04 AM EDT - Market open
Nektar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $153 | Buy | Maintains | $153 | +100.18% | Aug 6, 2026 |
| Citi | Citi | Buy Maintains $151 | Buy | Maintains | $151 | +97.57% | Jul 21, 2026 |
| BTIG | BTIG | Buy Reiterates $178 | Buy | Reiterates | $178 | +132.89% | Jul 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $185 | Buy | Reiterates | $185 | +142.05% | Jul 1, 2026 |
| Wedbush | Wedbush | Hold Maintains $95 → $80 | Hold | Maintains | $95 → $80 | +4.67% | May 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $140 | Buy | Maintains | $140 | +83.17% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $105 → $192 | Buy | Maintains | $105 → $192 | +151.21% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.